Patients

Search

Categories

adenocarcinoma
Adenocarcinoma
All tumor types
Bladder Cancer / UCC / Urothelial Cancer
BRAF mutation
Breast Cancer / Breast Carcinoma
CCNE1 amplification
Cervical Cancer / Cervical Carcinoma / Cervix Carcinoma
Cholangiocarcinoma
cMet driving mutation
cMet exon 14 mutation
CRC / Colorectal Cancer
EGFR exon 20 insertion
EGFR mutation
EGFR mutation
EGFR mutation
Endometrial Cancer / Endometrial Carcinoma
Esophageal Cancer / Esophagus Carcinoma
FGFR1-3 amplification
FGFR1-3 mutation
FGFR1+, FGFR2+
Gastroesophageal cancer
Gastroesophageal junction, GEJ
Her2 amplification
HER2 amplification
HER2 amplification
HER2 amplification
HER2 amplification
HER2 amplification
Her2 mutation
HER2 mutation
HER2 mutation
HER2 mutation
HLA-A*02-01
HLA-A*02-01
HLA-A*02-01
HLA-A1 positive
HLA-A2 positive
HLA-A2 positive
HLA-A2 positive
HNSCC / Head and Neck Squamous Cell Carcinoma
HR+ Her2 negative
Intermediate mutational burden (≥ 12-16 mutations/Mb)
KRAS mutation
Lung Cancer / NSCLC / Non Small Cell Lung Cancer
Melanoma
Merkel Cell carcinoma, MCC
MET +
MET alteration
MET amplification
MET mutation
Microsatellite instability high
Myxoid/Round Cell Liposarcoma
no PDL1 cutoff
no PDL1 cutoff
NY-ESO positive
NY-ESO positive
Other / Uknown
Other / Unknown
Other / Unknown
Other / Unknown
Other / Unknown
Other / Unknown
Other / Unknown
Other / Unknown
Other / Unknown
Other / Unknown
Other / Unknown
Other/ unknown
Other/Unknown
Ovarian Cancer / Ovarian Carcinoma
PDL-1 amplified
PDL-1 positive
PDL-1 positive
PDL-1 positive
PDL1 positive
POLD1 mutation
POLE mutation
Prostate Cancer / Prostate Carcinoma
RAS mutation
Renal cell carcinoma, RCC
Squamous cell carcinoma (SCC) of the skin
Stomach Cancer / Gastric Cancer
Synovia sarcoma
TMB-H (≥10 mut/Mb, F1CDx assay), excluding dMMR/MSI-H tumors
TNBC, triple negative breast cancer
Uncategorized

Proudly powered by WordPress | Theme: nki by Underscores.me.

Nederlands (Dutch)
English